nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—ADORA2A—Monoamine Transport—SLC6A4—conduct disorder	0.0556	0.0556	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—CGA—conduct disorder	0.0482	0.0482	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—CGA—conduct disorder	0.0437	0.0437	CbGpPWpGaD
Pentoxifylline—PDE4B—G alpha (s) signalling events—CGA—conduct disorder	0.0405	0.0405	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—CGA—conduct disorder	0.0316	0.0316	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0305	0.0305	CbGpPWpGaD
Pentoxifylline—CYP1A2—Methylation—COMT—conduct disorder	0.0297	0.0297	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.023	0.023	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—DRD4—conduct disorder	0.0227	0.0227	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0195	0.0195	CbGpPWpGaD
Pentoxifylline—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0185	0.0185	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CGA—conduct disorder	0.0175	0.0175	CbGpPWpGaD
Pentoxifylline—ADORA2A—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.0172	0.0172	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—SLC6A4—conduct disorder	0.0166	0.0166	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—DRD4—conduct disorder	0.0156	0.0156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.015	0.015	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CGA—conduct disorder	0.0149	0.0149	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Other—HTR2A—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—DRD4—conduct disorder	0.0137	0.0137	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—SLC6A4—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0128	0.0128	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—EP300—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CGA—conduct disorder	0.0125	0.0125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—DRD4—conduct disorder	0.012	0.012	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CGA—conduct disorder	0.0115	0.0115	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0109	0.0109	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CGA—conduct disorder	0.00988	0.00988	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00985	0.00985	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00979	0.00979	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—DRD4—conduct disorder	0.00979	0.00979	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CGA—conduct disorder	0.00897	0.00897	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CGA—conduct disorder	0.00897	0.00897	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00844	0.00844	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CGA—conduct disorder	0.0084	0.0084	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00839	0.00839	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00833	0.00833	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—DRD4—conduct disorder	0.00832	0.00832	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CGA—conduct disorder	0.0083	0.0083	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CGA—conduct disorder	0.00815	0.00815	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CGA—conduct disorder	0.00763	0.00763	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CGA—conduct disorder	0.00754	0.00754	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00713	0.00713	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CGA—conduct disorder	0.00649	0.00649	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00643	0.00643	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—DRD4—conduct disorder	0.00643	0.00643	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—HTR2A—conduct disorder	0.00639	0.00639	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CGA—conduct disorder	0.00589	0.00589	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0057	0.0057	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—COMT—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—MAOA—conduct disorder	0.00562	0.00562	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—DRD4—conduct disorder	0.00553	0.00553	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00551	0.00551	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—HTR2A—conduct disorder	0.00543	0.00543	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—EP300—conduct disorder	0.00539	0.00539	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CGA—conduct disorder	0.0053	0.0053	CbGpPWpGaD
Pentoxifylline—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00521	0.00521	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—DRD4—conduct disorder	0.00502	0.00502	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—DRD4—conduct disorder	0.00502	0.00502	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CGA—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—DRD4—conduct disorder	0.0047	0.0047	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—DRD4—conduct disorder	0.00465	0.00465	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—DRD4—conduct disorder	0.00456	0.00456	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—EP300—conduct disorder	0.00454	0.00454	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CGA—conduct disorder	0.00451	0.00451	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CGA—conduct disorder	0.00445	0.00445	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—DRD4—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—WASF1—conduct disorder	0.00425	0.00425	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—DRD4—conduct disorder	0.00422	0.00422	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—HTR2A—conduct disorder	0.00419	0.00419	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—EP300—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—WASF1—conduct disorder	0.00386	0.00386	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00375	0.00375	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00375	0.00375	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—DRD4—conduct disorder	0.00363	0.00363	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—WASF1—conduct disorder	0.00361	0.00361	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.00361	0.00361	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—WASF1—conduct disorder	0.00357	0.00357	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CGA—conduct disorder	0.00348	0.00348	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—DRD4—conduct disorder	0.0033	0.0033	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HTR2A—conduct disorder	0.00328	0.00328	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—HTR2A—conduct disorder	0.00328	0.00328	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—HTR2A—conduct disorder	0.00307	0.00307	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00305	0.00305	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—HTR2A—conduct disorder	0.00303	0.00303	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00303	0.00303	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00301	0.00301	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HTR2A—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—DRD4—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—WASF1—conduct disorder	0.00279	0.00279	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HTR2A—conduct disorder	0.00279	0.00279	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HTR2A—conduct disorder	0.00275	0.00275	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—DRD4—conduct disorder	0.0027	0.0027	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—DRD4—conduct disorder	0.00252	0.00252	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—DRD4—conduct disorder	0.00249	0.00249	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—EP300—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.00237	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—conduct disorder	0.00215	0.00215	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DRD4—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CGA—conduct disorder	0.00115	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EP300—conduct disorder	0.00103	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EP300—conduct disorder	0.000932	0.000932	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EP300—conduct disorder	0.000872	0.000872	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EP300—conduct disorder	0.000862	0.000862	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EP300—conduct disorder	0.000674	0.000674	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COMT—conduct disorder	0.000521	0.000521	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MAOA—conduct disorder	0.000518	0.000518	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000502	0.000502	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EP300—conduct disorder	0.000224	0.000224	CbGpPWpGaD
